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Abstract
Asthma	—	a  prolonged	 respiratory	 disease	 related	with	 hyper-responsiveness	 and	 increased	 inflammation	 of	 airways;	 affects	
millions	peoples	worldwide.	Vitamin	D	possess	anti-inflammatory	and	immunomodulatory	activities.	Its	deficiency	(the	level	less	
than	20	ng/mL	in	the	serum)	is	found	to	be	related	to	occurrence	of	pulmonary	diseases	including	bacterial	and	viral	infections	and	
asthma. Some studies indicate that low levels of vitamin D in the serum are related to reduced lung function and increased airway 
inflammation	as	well	as	overall	poor	results	in	asthmatic	patients.	Thus,	it	provides	positive	relation	between	vitamin	D	and	asthma.	
Increased prevalence of asthma over the past decades causes elevated interest in vitamin D supplementation that is even reported 
as	a ,,potential	therapeutic	option’’.	Unfortunately,	results	of	clinical	trials	are	inconsistent	and	do	not	provide	supportive	information	
about	positive	role	of	vitamin	D	in	asthma.	Little	or	even	no	effect	of	supplementation	of	vitamin	D	in	improvement	of	onset,	symptoms	
or progression of asthma was found in comprehensive interventional studies in adults, children and pregnant woman. This review 
critically	summarized	the	last	years	evidence	of	a relation	between	vitamin	D	and	asthma	in	adults,	children	and	pregnant	women.
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Introduction
In the past, vitamin D was only associat-
ed with its classical, skeletal action related to 
regulation of bone homeostasis. Nowadays, its 
pleiotropic activity (vitamin D plays a  role in 
many physiological processes) is also known [1]. 
Vitamin D deficiency affects approximately one 
billion people worldwide and is connected with 
development of many diseases including asthma 
[2]. This review critically discusses the relation 
between vitamin D and asthma in children, preg-
nant women and adults. 
Vitamin D synthesis, metabolism  
and mechanism of action
Humans may obtain vitamin D via two major 
sources: endogenous synthesis in the skin after 
UVB light exposure and diet (intake of vitamin 
D rich products such as fish, fish oils, egg yolk, 
liver and dietary supplements) [3, 4]. In the skin, 
7-dehydrocholesterol is converted to previtamin 
D due to action of UVB rays and then transformed 
to cholecalciferol via thermally induced isomer-
ization. Afterwards, vitamin D is hydroxylated 
to 25-hydroxyvitamin D (25[OH]D) — the circu-
lating metabolite of vitamin D in the liver. The 
binding of 25(OH)D to vitamin D-binding protein 
(VDBP) ensures its stability in the circulation [3, 
5, 6]. In the kidneys, 25[OH]D is hydroxylated to 
1,25 dihydroxy-vitamin D (1,25[OH]2D) — active 
form of vitamin D; calcitriol; by acting 1-a-hy-
droxylase (cytochrome P-450 [CYP] 27B1) en-
zyme. 1,25(OH)2D binds to vitamin D receptor 
(VDR) in the cytoplasm to show its intracellular 
biological activity. The 1,25(OH)2D + VDR com-
plex forms a heterodimer with retinoid X receptor 
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(RXR). Translocation of 1,25(OH)2D + VDR + 
RXR to the nucleus and its subsequent binding to 
vitamin D response element (VDRE) leads to the 
repression or activation of vitamin D-dependent 
gene transcription [3, 4, 6, 7].
What may determine the level of vitamin D?
The concentration of vitamin D in the se-
rum less than 20 ng/mL (less than 50 nmol/L) 
is defined as vitamin D deficiency, whereas the 
concentration of vitamin D in the serum higher 
than 20 ng/ml but less than 30 ng/mL is defined 
as vitamin D insufficiency [8–10]. The results of 
epidemiological studies indicate that there are 
many factors which may determine the concen-
tration of 25(OH)D in the serum, including age, 
sun exposure, diet, pigmentation of the skin color 
(people with lighter skin have higher levels of 
vitamin D as compared to people with heavily pig-
mented skin), sex, vitamin D fortification as well 
as latitude of residence (lower latitudes create an 
increased opportunity for endogenous synthesis 
of vitamin D in the skin) [4]. Despite the fact that 
research carried out in the past decades provided 
more valuable information about vitamin D and 
its mechanism of action, both insufficiency as 
well as deficiency of vitamin D have increased in 
the population worldwide. Some studies indicate 
that intake of multivitamins and food fortification 
do not decrease the prevalence of vitamin D de-
ficiency in developing countries, even in sunny 
areas. It may be associated with lifestyle changes 
such as reduced sunlight exposure, increased 
indoor activities, dietary changes and the use of 
sunscreen [8, 9]. Nowadays, recommended doses 
of vitamin D for fortification of food are not suf-
ficient and adequate for prevention of vitamin D 
deficiency and insufficiency. Additionally, there 
are other factors that may affect the levels of 
25(OH)D in the serum, such as sex, race, single 
nucleotide polymorphisms (SNPs) in VDRs and 
VDBPs and pharmacogenic factors in metabolism 
of vitamin D [5].
The role of vitamin D in asthma pathogenesis
Vitamin D acts as a potential immunomod-
ulator of inflammatory cells involved in asthma 
pathogenesis. The Figure 1 summarizes the im-
munomodulatory activity of vitamin D in asth-
ma-related inflammatory cells. 
The role of vitamin D in the asthma pathogen-
esis still attracts attention of many researchers. The 
importance of vitamin D in asthma background 
has been the main point of the studies carried out 
by several research groups in the past 2 decades. 
Phospholipases A2 (PLA2s) are enzymes that 
provide arachidonic acid through hydrolyzation 
of phospholipids. Arachidonic acid is a substrate 
for production of lipid inflammatory mediators 
(eicosanoids) involved in asthma pathogenesis 
[11]. Unpublished results of our studies indicate 
that 1,25(OH)2D3 may decrease expression of 
PLA2s via Ubiquitin C, NF-kB signaling pathway 
(studies were carried out in the Immunopathology 
Department (2016/2017), Medical University of 
Lodz, Poland). 
Some studies have shown a link between asth-
ma symptoms as well as poor lung function and 
vitamin D deficiency in asthma patients [9, 12]. 
Several genetic studies identified the correlation 
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Figure 1.	Immunomodulatory	activity	of	vitamin	D	on	inflammatory	cells	involved	in	pathogenesis	of	asthma	[1,	5]
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between some gene polymorphisms of VDBP and 
VDR and elevated susceptibility to asthma [13]. 
The results of meta-analysis and epidemiological 
studies have shown that decreased serum levels 
of vitamin D in children are related to decreased 
function of the lungs; an elevated risk for asthma, 
exacerbations and symptoms in asthma children 
[10]. Moreover, low maternal levels of vitamin 
D and decreased intake of vitamin D during 
pregnancy may be associated with increased 
likelihood of wheezing in the offspring [8, 9]. 
Findings from many studies have indicated that 
vitamin D may act on structural cells of the air-
ways as well as both innate and adaptive immune 
systems` cells. In addition, vitamin D deficiency 
promotes inflammation, however, vitamin D sup-
plementation reduces these effects [4, 7, 12, 14, 
15]. Unfortunately, results obtained from clinical 
trials are not consistent. The role of vitamin D 
supplementation as an adjunct or alternative 
therapy method in patients with asthma is still 
debatable.
Vitamin D and asthma — an overview of data 
from the last years
Children
The number of children suffering from asth-
ma has increased in the past 5 decades. Now-
adays, ~6.3 million children worldwide have 
asthma — one of the most common chronic dis-
eases among children aged < 18. An increased 
number of children with asthma may be the 
result of environmental microbial changes and 
urbanization [16]. 
The majority of vitamin D functions are me-
diated by VDR. Some VDR gene SNPs change the 
functions of vitamin D and are related to different 
pathological conditions. The relation between the 
effect of vitamin D and VDR SNPs on asthma has 
been also proposed.
SNPs in the VDR gene and vitamin D deficien-
cy has been correlated with asthma development. 
The measurements of 25(OH)D levels and analy-
sis of SNPs: ApaI, FokI and TaqI were carried out 
to determine the relation between the levels of 
vitamin D and frequency of following SNPs in the 
VDR gene in persistent asthma children and con-
trols. The significant differences between the FokI 
C allele and vitamin D insufficiency were found. 
Moreover, no dissimilarities between both ApaI, 
TaqI and the levels of vitamin D were shown [17].
Zhao et al. [18] summarized the relationship 
between polymorphisms of the VDR gene: FokI, 
BsmI, TaqI, ApaI and childhood asthma in me-
ta-analysis. FokI polymorphism may play a role 
in white pediatric patients with asthma, whereas 
ApaI polymorphism may be related to childhood 
asthma. No relation was found between Taq 
I polymorphism and a risk of asthma in children. 
BsmI polymorphism may slightly affect develop-
ment of childhood asthma.
Some studies have found association be-
tween a decreased level of vitamin D and exacer-
bation of symptoms in asthmatic children [4, 10, 
19, 20]. The results of the Puerto Rican children 
study have shown that vitamin D insufficiency 
may be associated with elevated odds of asthma 
exacerbations independently of time spent out-
doors, severity and control markers of disease, 
atopy, African racial ancestry [21]. A significantly 
decreased level of vitamin D in the asthmatic 
children serum, as compared to the control group, 
was also found in the study based on the analysis 
of the level of 25(OH)D in 1–4 year-old preschool-
ers with asthma and in healthy subjects. In the 
group of children with vitamin D deficiency, the 
total number of exacerbations in the previous year 
was much higher as compared to the group of chil-
dren with vitamin D sufficiency. The probability 
of controlled asthma was lower in the vitamin 
D deficiency group and higher in the vitamin D 
sufficiency group. Thus, the obtained results have 
shown a positive relation between asthma control 
and vitamin D level in the serum [22]. Similarly, 
a cross-sectional survey has shown a positive 
correlation between the level of vitamin D and 
asthma control in Italian children. Vitamin D de-
ficiency and insufficiency have been related with 
reduced asthma control and pulmonary function 
in a study population from northern Italy [23]. 
Significant improvement of asthma control in 
the vitamin D group (54 children), as compared 
to placebo group (35 children), was observed in 
Japanese schoolchildren. Short-term, low-dose 
supplementation of vitamin D as addition to 
standard asthma therapy may improve asthma 
control in schoolchildren [24].
The results of a double-blind, randomized, 
placebo-controlled study have shown that vita-
min D supplementation may rapidly elevate the 
level of serum 25(OH)D in asthmatic preschool 
patients. All of preschoolers in the study group 
(100% of the subjects) had level of ≥ 75 nmol/L (> 
30 ng/mL) serum 25(OH)D after 3 months of sup-
plementation [5, 25]. Similarly, supplementation 
of 2000 IU/d vitamin D for 15 weeks lead to an 
increased level of serum 25(OH)D and a reduced 
number of asthma-related missed schooldays in 
children from Ireland. Interestingly, no changes in 
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parameters of asthma in comparison to the placebo 
group were found [26]. Improvement in asthma 
control was also revealed in children supplement-
ed with 800 IU/d vitamin D for 2 months — accord-
ing to the results of the study from Japan assessing 
severity and frequency of asthma [24]. Moreover, 
vitamin D supplementation was proposed as an 
adjunct to standard asthma treatment [27].
Asthma is a heterogeneous pulmonary dis-
ease, thus the approach to achieve its better 
control and to stop its progression should require 
more targeted treatment in accordance with differ-
ent phenotypes of the condition. Numerous stud-
ies have been carried out to delineate phenotypes 
of asthma in children [28]. Better understanding 
of the disease phenotypes in youngsters may help 
in identifying potential targets for the preven-
tion of progression and development of asthma 
in children. It is not excluded that vitamin D is 
a potential promising candidate for such strategy.
The findings from several studies have pro-
vided no evidence of correlation between vitamin 
D insufficiency or deficiency and overall poor 
outcomes in patients with asthma. No relation 
between the level of vitamin D and airway in-
flammation, airway reactivity as well as allergy 
has been found in non-obese, not receiving an-
ti-inflammatory treatment children with asthma 
[20]. The findings from meta-analysis have shown 
that the relation between the level of vitamin D 
and the incidence of asthma, asthma control and 
lung functions are inconclusive. Non-asthmatic 
children have an upper level of 25(OH)D as 
compared to asthmatic children. However, the 
studies focused on a linking correlation between 
the level of 25(OH)D and lung functions; asthma 
incidence and control had mixed results. The 
author of meta-analysis also highlighted strengths 
(rigorous data analysis and extraction, broad 
search strategy) and limitations (i.e. significant 
heterogeneity among studies based on different 
methods of vitamin D measurement in various 
researches) of review [29]. Interestingly, Dogru 
et al. [30] observed that vitamin D deficiency is 
common in both control and asthma patients. 
However, the number of exacerbations and sever-
ity of disease is associated with vitamin D level. 
According to the World Allergy Organization, 
there is no support for hypothesis that vitamin D 
supplementation may reduce the risk of allergic 
diseases development in children. Moreover, it 
has been suggested that vitamin D supplemen-
tation in pregnant women, healthy infants and 
breastfeeding mothers has not prevented allergic 
diseases [31]. 
Results obtained from clinical trials are not 
conclusive. Additional studies must be performed 
in order to determine the role of vitamin D defi-
ciency or insufficiency in the onset, appearance 
of symptoms and control of asthma in children. 
Pregnant women
Several studies have been conducted to find 
out how maternal diet may be related to devel-
opment of asthma in children. The results of 
a prospective cohort study (1724 children from 
Spain) have shown a relation between increased 
maternal vitamin D intake and decreased risk of 
infections of the lower respiratory tract in chil-
dren during first year of life but no relation with 
asthma and wheezing [32]. Camargo et al. [33] 
have observed an inverse relation between cord-
blood 25(OH)D level and childhood wheezing 
as well as respiratory infection risk but no such 
relation was found with asthma [33]. The level of 
fetal and maternal 25(OH)D at birth, midgestation 
and airway resistance of 6-year-old offspring was 
measured in order to evaluate the relation be-
tween the level of 25(OH)D and childhood asthma 
as well as lung function. No relation was found 
between 25(OH)D level at midgestation and air-
way resistance in 6-year-old offspring. However, 
a decreased 25(OH)D level at birth may be related 
to increased airway resistance in childhood [34]. 
Zosky et al. [35] showed the relationship between 
maternal vitamin D deficiency (16–20-week ges-
tation) and impaired function of the lung as well 
as development of asthma at the age of 6 [35]. 
The results of the study from Taiwan have 
shown significant relations between maternal and 
cord blood level of 25(OH)D and a decreased level 
of vitamin D in children with vitamin D deficient 
mother. Moreover, maternal vitamin D deficiency 
may be also associated with allergen sensitization 
prevalence in < 2-year-old children [36].
The results obtained from a double-blind, 
randomized, parallel-group, placebo-controlled 
trial have revealed that supplementation of wom-
en (1000 IU/2000 IU) and infants (400 IU/800 IU) 
decreased sensitization of children to mites at 18 
months [37].
Adults
The VDR gene may be determined as a pleio-
tropic gene related to multiple inflammatory, 
autoimmune and allergy diseases. The results 
of a meta-analysis have indicated that polymor-
phisms of the VDR gene may be associated with 
increased asthma susceptibility. VDR polymor-
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phisms had been also proposed as option for 
consideration as biomarkers for susceptibility 
of asthma [38]. Shahin et al. [39] have observed 
a decreased level of vitamin D in patients with 
asthma as compared to controls (70 adult patients 
with asthma [vitamin D level: 19.88 ± 9.6 ng.mL]; 
20 controls [vitamin D level: 33.5 ± 6.1 ng/mL]).
A decreased level of serum 25(OH)D (less 
than 30 ng/mL) is common in adult patients with 
uncontrolled and/or severe asthma. Moreover, 
the patients with eosinophilic disease or treated 
with oral corticosteroids have an increased risk of 
vitamin D insufficiency [40]. The effect of using 
medium and small doses of inhaled glucocorti-
costeroids on skeletal mineral density have not 
been noticed. However, higher doses of inhaled 
glucocorticosteroids may cause bone mineraliza-
tion disorders [41]. In the group of patients treat-
ed with high doses of budesonide together with 
vitamin D, inhibition of the resorption process in 
bones was observed while there were no changes 
in the concentrations of backbone markers [42].
A  low level of vitamin D (less than 20 ng/
mL) is related to an elevated risk of asthma in 
adults and adolescence — as it has been reported 
by the study from Canada [43]. In adult Turkish 
patients with asthma, lower levels of vitamin D 
were related to poor asthma control, pulmonary 
function and lower absolute FEV1 values [44]. 
Interestingly, the study of the Danish popula-
tion (30–60-year-old) has shown no effect of serum 
vitamin D level on asthma and allergy develop-
ment in adults [45]. Similarly, a case-control study 
also has identified no relation between a  lower 
vitamin D level and asthma development [46]. 
The level of 1,25(OH)2D, 25(OH)D and VDBP 
increased in BALF 24 hours after allergen chal-
lenge [47]. In Korean adults, a decreased level 
of 25(OH)D was positively correlated with the 
concentration of total IgE. A significantly lower 
level of serum 25(OH)D was observed in patients 
with a history of atopic dermatitis or asthma as 
compared to healthy controls [48]. The findings 
obtained from a  retrospective analysis have 
shown that vitamin D sufficiency is related to 
reduction of asthma exacerbations and emergency 
department visits. Vitamin D was proposed as 
a modifiable risk factor for asthma exacerbations` 
severity. However, the obtained results have not 
confirmed the outcome of other studies present-
ing a relation between vitamin D deficiency and 
reduced FEV1 or obesity. Symptomatic asthmatics 
may be limited by allergy or may avoid outdoor 
physical activities, thus denying sunlight expo-
sure and endogenous synthesis of vitamin D. 
Therefore, it may be hypothesized that the oc-
currence of asthma may be casual of vitamin D 
deficiency and not the other way around. Because 
of this theory, it would be expected that patients 
with severe asthma would have further decreased 
level of vitamin D, however, it was not observed 
in the study population. Moreover, it may be 
possible that the cause of vitamin D deficiency 
is multifactorial and not related only to limited 
sun exposure [49]. A cross-sectional, multicenter 
study of the United Kingdom population has 
shown that adult corticosteroid-treated patients 
with asthma have a decreased status of vitamin D 
related to nonwhite ethnicity, non-use of vitamin 
D supplement, unemployment, higher body mass 
index but not genetic determinants [50]. Similar-
ly, no significant relation between serum level of 
vitamin D and prevalence of asthma, atopy and 
wheezing in adults was found in the study of the 
Denmark population either [45].
Vitamin D and Lung Function Decline in 
Adults with Asthma (HUNT) study in Norway 
indicated greater declines in FEV1/FVC ratio 
FVC and FEV1 in patients with a decreased level 
of 25(OH)D as compared to patients with a high 
level of vitamin D. Basing on the obtained results, 
a poor relation between vitamin D insufficiency 
and decline in lung function was found in adult 
asthma patients [51].
Viral infections of the airways play an im-
portant role in exacerbations, progression and 
onset of asthma [52]. The importance of vitamin 
D in the prevention of upper respiratory tract 
infections or exacerbations was determined in 
a placebo-controlled, randomized double-blind 
trial from London. Asthma patients were supple-
mented with vitamin D for 1 year (6 doses, every 
2 months). The obtained results have shown no 
effect of vitamin D supplementation on upper 
respiratory tract infections or exacerbations [53]. 
Vitamin D supplementation does not support the 
reduction of frequency and severity of cold in 
corticosteroid-inhaled mild to moderate asthma 
patients [54]. 
The results of the studies aimed at deter-
mination of association between vitamin D and 
asthma are still inconclusive. To better determine 
the nature of vitamin D-asthma relation, more 
targeted studies need to be conducted.
Conclusion
The number of people with vitamin D defi-
ciency is still growing despite the increased inter-
est and knowledge about certain food fortification 
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and mechanism of vitamin D action. The potential 
role of vitamin D in the pathogenesis of asthma is 
still not fully known. The results obtained from 
the studies focused on the role of vitamin D in the 
asthma pathogenesis and beneficial effects of vita-
min D in asthma patients are inconclusive. Even 
though vitamin D supplementation was proposed 
as adjunct therapy option for asthma patients, 
the results of some clinical trials have identified 
very little or even barely no efficacy of vitamin 
D supplementation in improvement of onset and 
symptoms in asthma patients. Despite the fact that 
the studies carried out in these fields provide many 
valuable information on vitamin D-asthma relation, 
some studies have indicated no effect of vitamin 
D supplementation on exacerbation and asthma 
control. It is highly possible that these studies may 
have some limitations, i.e. variations in vitamin D 
dosage, duration of trials and limited sample sizes, 
all contributing to the observed results. Moreover, 
the consensus between determination of ”vitamin 
D deficiency” and ”vitamin D insufficiency” level is 
needed. The prevalence of vitamin D insufficiency 
and deficiency differs from ”country to country”. 
Thus, there is a need for randomized ”well-conduct-
ed” trials of vitamin D supplementation (different 
vitamin D doses and supplementation duration) to 
estimate the effectiveness of vitamin D supplemen-
tation in asthma control and lung function. In future 
research, the optimal dose of vitamin D in various 
populations distinguished by age, ethnicity, sex, 
cultural practices, phenotypes of asthma, factors 
playing a role in absorption of vitamin D should 
be taken into consideration during design of the 
studies. Thus, despite the inconclusive results of 
clinical trials, it is highly probable that vitamin 
D can help in achieving asthma control due to its 
immunomodulatory effects on inflammatory cells 
involved in asthma pathogenesis and its anti-in-
flammatory activities.
Currently, it is impossible to determine 
whether vitamin D supplementation improves 
treatment and control of asthma. As mentioned 
before, research data concerning the subject is in-
conclusive but this standpoint may change in the 
future once more refined research is carried out. 
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